LabMedica

Download Mobile App
Recent News Expo Clinical Chem. Molecular Diagnostics Hematology Immunology Microbiology Pathology Technology Industry Focus

Disrupted Genetic Systems Discovered in Autistic Brain

By LabMedica International staff writers
Posted on 17 May 2012
Print article
By investigating gene collections rather than individual genes, researchers have now identified specific functional systems with genetic disruptions in the autistic brain.

Autism, the severe state resulting from multiple neurodevelopmental disorders named autism spectrum disorders (ASDs), is known to have a strong genetic basis. However, efforts to identify the responsible genes have so far had mixed results due to the influence of many different genes as well as that different genes are involved in different autistic individuals. Scientists at the Hebrew University of Jerusalem (HUJ; Jerusalem, Israel) chose to examine groups of genes to identify and better understand multiple pathways involved in ASDs.

The study, published in the journal PLoS Genetics in March 2012, showed that the different genes involved in autism tend to be involved in specific brain processes. This can explain similarities in the behavioral symptoms of different autistics as well as the large spectrum of behaviors observed in different autistic individuals.

The main goal of the project, conducted by Dr. Sagiv Shifman and his doctoral student Eyal Ben-David at the HUJ Department of Genetics, was to test the contribution of rare genetic mutations as well as genetic variations common in the population, and to see whether these different types of genetic risk factors are related. To that end, the scientists used the Allen Brain Atlas RNA microarray dataset to construct a robust network of the human brain transcriptome based on the expression pattern of genes across different brain areas. This allowed them to discover groups of genes with shared function in the brain. Next, based on genetic data from thousands of families with autistic children, the researchers studied the contribution of different groups of genes to autism.

To their surprise, they found -- when looking at mutations found in autism as well as thousands of common gene variants that are more frequently seen in autistics -- that these mutations and variations are located in specific functional groups, that the genetic risk factors were enriched in specific groups of connected genes. When looking at families with one autistic individual (sporadic cases), and in families where there is more than one affected individual (multiplex cases), the same variants were seen acting in both cases. These groups of genes are highly active in the first year of life, and the strongest enriched of risk factors corresponded to a group of genes involved in processes of learning, memory, and sensory perception.

Shifman and Ben-David believe their work could help pave the way for development of genetic scans for early diagnosis of autism, and, by concentrating on specific gene groups, for the design of effective therapeutic drugs that could alleviate symptoms in autistics with different genetic backgrounds.

Related Links:

Hebrew University of Jerusalem


Gold Member
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
Verification Panels for Assay Development & QC
Seroconversion Panels
New
Total 25-Hydroxyvitamin D₂ & D₃ Assay
Total 25-Hydroxyvitamin D₂ & D₃ Assay
New
Fecal DNA Extraction Kit
QIAamp PowerFecal Pro DNA Kit

Print article

Channels

Molecular Diagnostics

view channel
Image: The Mirvie RNA platform predicts pregnancy complications months before they occur using a simple blood test (Photo courtesy of Mirvie)

RNA-Based Blood Test Detects Preeclampsia Risk Months Before Symptoms

Preeclampsia remains a major cause of maternal morbidity and mortality, as well as preterm births. Despite current guidelines that aim to identify pregnant women at increased risk of preeclampsia using... Read more

Immunology

view channel
Image: The cancer stem cell test can accurately choose more effective treatments (Photo courtesy of University of Cincinnati)

Stem Cell Test Predicts Treatment Outcome for Patients with Platinum-Resistant Ovarian Cancer

Epithelial ovarian cancer frequently responds to chemotherapy initially, but eventually, the tumor develops resistance to the therapy, leading to regrowth. This resistance is partially due to the activation... Read more

Microbiology

view channel
Image: The lab-in-tube assay could improve TB diagnoses in rural or resource-limited areas (Photo courtesy of Kenny Lass/Tulane University)

Handheld Device Deliver Low-Cost TB Results in Less Than One Hour

Tuberculosis (TB) remains the deadliest infectious disease globally, affecting an estimated 10 million people annually. In 2021, about 4.2 million TB cases went undiagnosed or unreported, mainly due to... Read more

Technology

view channel
Image: Schematic illustration of the chip (Photo courtesy of Biosensors and Bioelectronics, DOI: https://doi.org/10.1016/j.bios.2025.117401)

Pain-On-A-Chip Microfluidic Device Determines Types of Chronic Pain from Blood Samples

Chronic pain is a widespread condition that remains difficult to manage, and existing clinical methods for its treatment rely largely on self-reporting, which can be subjective and especially problematic... Read more

Industry

view channel
Image: The collaboration aims to leverage Oxford Nanopore\'s sequencing platform and Cepheid\'s GeneXpert system to advance the field of sequencing for infectious diseases (Photo courtesy of Cepheid)

Cepheid and Oxford Nanopore Technologies Partner on Advancing Automated Sequencing-Based Solutions

Cepheid (Sunnyvale, CA, USA), a leading molecular diagnostics company, and Oxford Nanopore Technologies (Oxford, UK), the company behind a new generation of sequencing-based molecular analysis technologies,... Read more
Sekisui Diagnostics UK Ltd.